Infectious Diseases
Infectious Diseases market is segmented by players, region (country), by Type and by Application. ... Read More
Global Infectious Disease Testing Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Technology
1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology: 2017 VS 2021 VS 2028
1.2.2 Immunodiagnostics
1.2.3 Clinical Microbiology
1.2.4 PCR
1.2.5 INAAT
1.2.6 DNA Sequencing & NGS
1.2.7 DNA Microarrays
1.2.8 Other
1.3 Market by Application
1.3.1 Global Infectious Disease Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals/Clinical Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic/Research Institutes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Testing Market Perspective (2017-2028)
2.2 Infectious Disease Testing Growth Trends by Region
2.2.1 Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Testing Market Dynamics
2.3.1 Infectious Disease Testing Industry Trends
2.3.2 Infectious Disease Testing Market Drivers
2.3.3 Infectious Disease Testing Market Challenges
2.3.4 Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Testing Players by Revenue
3.1.1 Global Top Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Testing Revenue
3.4 Global Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2021
3.5 Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Testing Breakdown Data by Technology
4.1 Global Infectious Disease Testing Historic Market Size by Technology (2017-2022)
4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2023-2028)
5 Infectious Disease Testing Breakdown Data by Application
5.1 Global Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Testing Market Size (2017-2028)
6.2 North America Infectious Disease Testing Market Size by Country (2017-2022)
6.3 North America Infectious Disease Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Infectious Disease Testing Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Infectious Disease Testing Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Disease Testing Introduction
11.2.4 Abbott Revenue in Infectious Disease Testing Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Beckman Coulter Diagnostics
11.3.1 Beckman Coulter Diagnostics Company Detail
11.3.2 Beckman Coulter Diagnostics Business Overview
11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction
11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2017-2022)
11.3.5 Beckman Coulter Diagnostics Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Infectious Disease Testing Introduction
11.4.4 Roche Revenue in Infectious Disease Testing Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Detail
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Infectious Disease Testing Introduction
11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2017-2022)
11.5.5 Siemens Healthcare Recent Development
11.6 Abaxis
11.6.1 Abaxis Company Detail
11.6.2 Abaxis Business Overview
11.6.3 Abaxis Infectious Disease Testing Introduction
11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2017-2022)
11.6.5 Abaxis Recent Development
11.7 Acon Laboratories
11.7.1 Acon Laboratories Company Detail
11.7.2 Acon Laboratories Business Overview
11.7.3 Acon Laboratories Infectious Disease Testing Introduction
11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2017-2022)
11.7.5 Acon Laboratories Recent Development
11.8 Avioq
11.8.1 Avioq Company Detail
11.8.2 Avioq Business Overview
11.8.3 Avioq Infectious Disease Testing Introduction
11.8.4 Avioq Revenue in Infectious Disease Testing Business (2017-2022)
11.8.5 Avioq Recent Development
11.9 BD
11.9.1 BD Company Detail
11.9.2 BD Business Overview
11.9.3 BD Infectious Disease Testing Introduction
11.9.4 BD Revenue in Infectious Disease Testing Business (2017-2022)
11.9.5 BD Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2017-2022)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Cavidi
11.11.1 Cavidi Company Detail
11.11.2 Cavidi Business Overview
11.11.3 Cavidi Infectious Disease Testing Introduction
11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2017-2022)
11.11.5 Cavidi Recent Development
11.12 Cepheid
11.12.1 Cepheid Company Detail
11.12.2 Cepheid Business Overview
11.12.3 Cepheid Infectious Disease Testing Introduction
11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2017-2022)
11.12.5 Cepheid Recent Development
11.13 Chembio Diagnostic Systems
11.13.1 Chembio Diagnostic Systems Company Detail
11.13.2 Chembio Diagnostic Systems Business Overview
11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction
11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2017-2022)
11.13.5 Chembio Diagnostic Systems Recent Development
11.14 Clarity Diagnostics
11.14.1 Clarity Diagnostics Company Detail
11.14.2 Clarity Diagnostics Business Overview
11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction
11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2017-2022)
11.14.5 Clarity Diagnostics Recent Development
11.15 EMD Millipore
11.15.1 EMD Millipore Company Detail
11.15.2 EMD Millipore Business Overview
11.15.3 EMD Millipore Infectious Disease Testing Introduction
11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2017-2022)
11.15.5 EMD Millipore Recent Development
11.16 Epitope Diagnostic
11.16.1 Epitope Diagnostic Company Detail
11.16.2 Epitope Diagnostic Business Overview
11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction
11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2017-2022)
11.16.5 Epitope Diagnostic Recent Development
11.17 Gold Standard Diagnostics
11.17.1 Gold Standard Diagnostics Company Detail
11.17.2 Gold Standard Diagnostics Business Overview
11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction
11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2017-2022)
11.17.5 Gold Standard Diagnostics Recent Development
11.18 Hologic
11.18.1 Hologic Company Detail
11.18.2 Hologic Business Overview
11.18.3 Hologic Infectious Disease Testing Introduction
11.18.4 Hologic Revenue in Infectious Disease Testing Business (2017-2022)
11.18.5 Hologic Recent Development
11.19 Immunetics
11.19.1 Immunetics Company Detail
11.19.2 Immunetics Business Overview
11.19.3 Immunetics Infectious Disease Testing Introduction
11.19.4 Immunetics Revenue in Infectious Disease Testing Business (2017-2022)
11.19.5 Immunetics Recent Development
11.20 InBios International
11.20.1 InBios International Company Detail
11.20.2 InBios International Business Overview
11.20.3 InBios International Infectious Disease Testing Introduction
11.20.4 InBios International Revenue in Infectious Disease Testing Business (2017-2022)
11.20.5 InBios International Recent Development
11.21 Life Technologies
11.21.1 Life Technologies Company Detail
11.21.2 Life Technologies Business Overview
11.21.3 Life Technologies Infectious Disease Testing Introduction
11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2017-2022)
11.21.5 Life Technologies Recent Development
11.22 Maxim Biomedical
11.22.1 Maxim Biomedical Company Detail
11.22.2 Maxim Biomedical Business Overview
11.22.3 Maxim Biomedical Infectious Disease Testing Introduction
11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2017-2022)
11.22.5 Maxim Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunodiagnostics
Table 3. Key Players of Clinical Microbiology
Table 4. Key Players of PCR
Table 5. Key Players of INAAT
Table 6. Key Players of DNA Sequencing & NGS
Table 7. Key Players of DNA Microarrays
Table 8. Key Players of Other
Table 9. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Infectious Disease Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Infectious Disease Testing Market Share by Region (2017-2022)
Table 13. Global Infectious Disease Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Infectious Disease Testing Market Share by Region (2023-2028)
Table 15. Infectious Disease Testing Market Trends
Table 16. Infectious Disease Testing Market Drivers
Table 17. Infectious Disease Testing Market Challenges
Table 18. Infectious Disease Testing Market Restraints
Table 19. Global Infectious Disease Testing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Infectious Disease Testing Market Share by Players (2017-2022)
Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2021)
Table 22. Ranking of Global Top Infectious Disease Testing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Infectious Disease Testing Product Solution and Service
Table 26. Date of Enter into Infectious Disease Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Disease Testing Market Size by Technology (2017-2022) & (US$ Million)
Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2017-2022)
Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2023-2028) & (US$ Million)
Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2023-2028)
Table 32. Global Infectious Disease Testing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Infectious Disease Testing Revenue Market Share by Application (2017-2022)
Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Infectious Disease Testing Revenue Market Share by Application (2023-2028)
Table 36. North America Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 39. Europe Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 40. Asia-Pacific Infectious Disease Testing Market Size by Region (2017-2022) & (US$ Million)
Table 41. Asia-Pacific Infectious Disease Testing Market Size by Region (2023-2028) & (US$ Million)
Table 42. Latin America Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 43. Latin America Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 44. Middle East & Africa Infectious Disease Testing Market Size by Country (2017-2022) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease Testing Market Size by Country (2023-2028) & (US$ Million)
Table 46. Abbott Diagnostics Company Detail
Table 47. Abbott Diagnostics Business Overview
Table 48. Abbott Diagnostics Infectious Disease Testing Product
Table 49. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 50. Abbott Diagnostics Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Infectious Disease Testing Product
Table 54. Abbott Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Beckman Coulter Diagnostics Company Detail
Table 57. Beckman Coulter Diagnostics Business Overview
Table 58. Beckman Coulter Diagnostics Infectious Disease Testing Product
Table 59. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 60. Beckman Coulter Diagnostics Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Infectious Disease Testing Product
Table 64. Roche Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Siemens Healthcare Company Detail
Table 67. Siemens Healthcare Business Overview
Table 68. Siemens Healthcare Infectious Disease Testing Product
Table 69. Siemens Healthcare Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 70. Siemens Healthcare Recent Development
Table 71. Abaxis Company Detail
Table 72. Abaxis Business Overview
Table 73. Abaxis Infectious Disease Testing Product
Table 74. Abaxis Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 75. Abaxis Recent Development
Table 76. Acon Laboratories Company Detail
Table 77. Acon Laboratories Business Overview
Table 78. Acon Laboratories Infectious Disease Testing Product
Table 79. Acon Laboratories Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 80. Acon Laboratories Recent Development
Table 81. Avioq Company Detail
Table 82. Avioq Business Overview
Table 83. Avioq Infectious Disease Testing Product
Table 84. Avioq Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 85. Avioq Recent Development
Table 86. BD Company Detail
Table 87. BD Business Overview
Table 88. BD Infectious Disease Testing Product
Table 89. BD Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 90. BD Recent Development
Table 91. Bio-Rad Laboratories Company Detail
Table 92. Bio-Rad Laboratories Business Overview
Table 93. Bio-Rad Laboratories Infectious Disease Testing Product
Table 94. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 95. Bio-Rad Laboratories Recent Development
Table 96. Cavidi Company Detail
Table 97. Cavidi Business Overview
Table 98. Cavidi Infectious Disease TestingProduct
Table 99. Cavidi Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 100. Cavidi Recent Development
Table 101. Cepheid Company Detail
Table 102. Cepheid Business Overview
Table 103. Cepheid Infectious Disease TestingProduct
Table 104. Cepheid Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 105. Cepheid Recent Development
Table 106. Chembio Diagnostic Systems Company Detail
Table 107. Chembio Diagnostic Systems Business Overview
Table 108. Chembio Diagnostic Systems Infectious Disease TestingProduct
Table 109. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 110. Chembio Diagnostic Systems Recent Development
Table 111. Clarity Diagnostics Company Detail
Table 112. Clarity Diagnostics Business Overview
Table 113. Clarity Diagnostics Infectious Disease TestingProduct
Table 114. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 115. Clarity Diagnostics Recent Development
Table 116. EMD Millipore Company Detail
Table 117. EMD Millipore Business Overview
Table 118. EMD Millipore Infectious Disease TestingProduct
Table 119. EMD Millipore Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 120. EMD Millipore Recent Development
Table 121. Epitope Diagnostic Company Detail
Table 122. Epitope Diagnostic Business Overview
Table 123. Epitope Diagnostic Infectious Disease TestingProduct
Table 124. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 125. Epitope Diagnostic Recent Development
Table 126. Gold Standard Diagnostics Company Detail
Table 127. Gold Standard Diagnostics Business Overview
Table 128. Gold Standard Diagnostics Infectious Disease TestingProduct
Table 129. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 130. Gold Standard Diagnostics Recent Development
Table 131. Hologic Company Detail
Table 132. Hologic Business Overview
Table 133. Hologic Infectious Disease TestingProduct
Table 134. Hologic Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 135. Hologic Recent Development
Table 136. Immunetics Company Detail
Table 137. Immunetics Business Overview
Table 138. Immunetics Infectious Disease TestingProduct
Table 139. Immunetics Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 140. Immunetics Recent Development
Table 141. InBios International Company Detail
Table 142. InBios International Business Overview
Table 143. InBios International Infectious Disease TestingProduct
Table 144. InBios International Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 145. InBios International Recent Development
Table 146. Life Technologies Company Detail
Table 147. Life Technologies Business Overview
Table 148. Life Technologies Infectious Disease TestingProduct
Table 149. Life Technologies Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 150. Life Technologies Recent Development
Table 151. Maxim Biomedical Company Detail
Table 152. Maxim Biomedical Business Overview
Table 153. Maxim Biomedical Infectious Disease TestingProduct
Table 154. Maxim Biomedical Revenue in Infectious Disease Testing Business (2017-2022) & (US$ Million)
Table 155. Maxim Biomedical Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Testing Market Share by Technology: 2021 VS 2028
Figure 2. Immunodiagnostics Features
Figure 3. Clinical Microbiology Features
Figure 4. PCR Features
Figure 5. INAAT Features
Figure 6. DNA Sequencing & NGS Features
Figure 7. DNA Microarrays Features
Figure 8. Other Features
Figure 9. Global Infectious Disease Testing Market Share by Application in 2021 & 2028
Figure 10. Hospitals/Clinical Laboratories Case Studies
Figure 11. Reference Laboratories Case Studies
Figure 12. Academic/Research Institutes Case Studies
Figure 13. Other Case Studies
Figure 14. Infectious Disease Testing Report Years Considered
Figure 15. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Infectious Disease Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Infectious Disease Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Infectious Disease Testing Market Share by Players in 2021
Figure 19. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2021
Figure 21. North America Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America Infectious Disease Testing Market Share by Country (2017-2028)
Figure 23. United States Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Infectious Disease Testing Market Share by Country (2017-2028)
Figure 27. Germany Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Infectious Disease Testing Market Share by Region (2017-2028)
Figure 35. China Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Infectious Disease Testing Market Share by Country (2017-2028)
Figure 43. Mexico Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Infectious Disease Testing Market Share by Country (2017-2028)
Figure 47. Turkey Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 50. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 51. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 52. Roche Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 53. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 54. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 55. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 56. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 57. BD Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 59. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 60. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 61. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 62. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 63. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 64. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 65. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 66. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 67. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 68. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 69. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 70. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Diagnostics Abbott Beckman Coulter Diagnostics Roche Siemens Healthcare Abaxis Acon Laboratories Avioq BD Bio-Rad Laboratories Cavidi Cepheid Chembio Diagnostic Systems Clarity Diagnostics EMD Millipore Epitope Diagnostic Gold Standard Diagnostics Hologic Immunetics InBios International Life Technologies Maxim Biomedical